Publication | Closed Access

Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial

Gastrointestinal OncologyMedicineAdjuvant CapecitabineClinical TrialsColorectal CancerPharmacotherapyCancer TreatmentOncologyRadiation OncologyQuasar 2Cancer ResearchHealth Sciences